Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edoxaban in Japanese patients with severe renal impairment undergoing orthopedic surgery
NCT01857583Phase 3Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Mar 2012
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of edoxaban in venous thromboembolism (VTE), sponsored by Daiichi Sankyo Co., Ltd.. Started Mar 2012; status: completed.
02
Drugs
edoxaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT01857583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01857583.